ICI’s NOLVADEX (TAMOXIFEN) PATENT IS "UNENFORCEABLE" IN FACE OF BARR’s CHALLENGE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".